Search Results - "White, Alan G"

Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review by Rice, J. Bradford, White, Alan G., Scarpati, Lauren M., Wan, George, Nelson, Winnie W.

“…While corticosteroids are relatively inexpensive and commonly used as treatment for a variety of conditions, long-term use is known to be associated with…”
Get full text

Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with Osteoarthritis by Silverman, Stuart, Schepman, Patricia, Rice, J Bradford, Beck, Craig G, Pajerowski, William, White, Alan G, Thakkar, Sheena, Robinson, Rebecca L, Emir, Birol

“…While prior research has shown that patients with osteoarthritis (OA) who are prescribed opioids have higher rates of falls and fractures following drug…”
Get full text

Direct and Indirect Costs of Pain Therapy for Osteoarthritis in an Insured Population in the United States by White, Alan G., Birnbaum, Howard G., Janagap, Carmela, Buteau, Sharon, Schein, Jeff

“…Objective: To assess the health care utilization and cost of illness for osteoarthritis (OA) patients taking pain medications. Specifically, the goah were to…”
Get full text

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States by Birnbaum, Howard G., White, Alan G., Schiller, Matt, Waldman, Tracy, Cleveland, Jody M., Roland, Carl L.

“…Objectives.  The objective of this study was to estimate the societal costs of prescription opioid abuse, dependence, and misuse in the United States. Methods…”
Get full text

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States by Silverman, Stuart, Rice, J. Bradford, White, Alan G., Beck, Craig G., Robinson, Rebecca L., Fernan, Catherine, Schepman, Patricia

“…In 2019, the American College of Rheumatology conditionally recommended tramadol and conditionally recommended against nontramadol opioids for patients with…”
Get full text

Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs by White, Alan G, LeCates, Joseph, Birnbaum, Howard G, Cheng, Wendy, Roland, Carl L, Mardekian, Jack

“…To quantify the potential impact of reductions in positive subjective measures from human abuse liability studies on real-world rates of nonmedical use of…”
Get more information

Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients by Yenikomshian, Mihran Ara, White, Alan G, Carson, Michael E, Garrison, Louis P, Oderda, Gary M, Biskupiak, Joseph E, Hlavacek, Patrick R, Roland, Carl L

“…To estimate healthcare resource utilization, associated costs, and number needed to harm (NNH) from a physician's decision to prescribe extended-release (ER)…”
Get more information

All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With Osteoarthritis by Silverman, Stuart, Thakkar, Sheena, Sell, Heather, White, Alan G., Downes, Nathaniel, Pajerowski, William, Robinson, Rebecca L., Beck, Craig G., Emir, Birol, Schepman, Patricia

“…IntroductionThis study estimated all-cause health care resource utilization (HRU) and costs and work loss outcomes associated with pain management of employed…”
Get full text

Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population by Rice, J. Bradford, White, Alan G., Johnson, Michaela, Wagh, Aneesha, Qin, Yimin, Bartels-Peculis, Laura, Ciepielewska, Gosia, Nelson, Winnie W.

“…Objective: This retrospective study assessed the incidence and timing of adverse events (AEs) among patients prescribed varying dose levels of corticosteroids…”
Get full text

Analytic models to identify patients at risk for prescription opioid abuse by White, Alan G, Birnbaum, Howard G, Schiller, Matt, Tang, Jackson, Katz, Nathaniel P

“…To assess the feasibility of using medical and prescription drug claims data to develop models that identify patients at risk for prescription opioid abuse or…”
Get full text

Assessment of Work Loss Associated With Prescription-Related Opioid Use Disorder: A Retrospective Analysis of Claims Data by White, Alan G., Spittle, Tim, Fernan, Catherine, Billmyer, Emma, Marrett, Elizabeth, Kwong, Winghan Jacqueline, Rossiter, Louis F.

“…Quantify work loss and costs associated with prescription opioid use disorder (OUD) from the employer perspective. Retrospective claims analysis to compare…”
Get full text

Predictors of High-cost Patients With Noninfectious Inflammatory Eye Diseases by Nelson, Winnie W., Rice, J. Bradford, White, Alan G., Johnson, Michaela, Reiff, Julie, Lima, Antonio Flavio, Bartels-Peculis, Laura, Ciepielewska, Gosia, Albini, Thomas A.

“…Noninfectious inflammatory eye diseases (NIIEDs), such as uveitis, is a general term used to describe a complex mix of acute, chronic, allergic, and…”
Get full text

A Model to Identify Patients at Risk for Prescription Opioid Abuse, Dependence, and Misuse by Rice, J. Bradford, White, Alan G., Birnbaum, Howard G., Schiller, Matt, Brown, David A., Roland, Carl L.

“…Objective.  The objective of this study was to use administrative claims data to identify and analyze patient characteristics and behavior associated with…”
Get full text

A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis by Silverman, Stuart, Schepman, Patricia, Rice, J Bradford, Robinson, Rebecca L, White, Alan G, Fernan, Catherine, Beck, Craig G

“…Osteoarthritis (OA) affects millions of adults in the United States and can result in substantial pain, functional impairment, and significant clinical and…”
Get full text

The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States by Rice, J. Bradford, White, Alan G., Galebach, Philip, Korenblat, Kevin M., Wagh, Aneesha, Lovelace, Belinda, Wan, George J., Jamil, Khurram

“…Background: This study evaluated the characteristics, healthcare resource utilization (HCRU), and costs, from the payer perspective, of hepatorenal syndrome…”
Get full text

Direct Costs of Opioid Abuse in an Insured Population in the United States by White, Alan G, Birnbaum, Howard G, Mareva, Milena N, Daher, Maham, Vallow, Susan, Schein, Jeff, Katz, Nathaniel

“…To (a) describe the demographics of opioid abusers; (b) compare the prevalence rates of selected comorbidities and the medical and drug utilization patterns of…”
Get full text

The burden of non-infectious intraocular inflammatory eye diseases: a systematic literature review by Rice, J. Bradford, White, Alan G., Scarpati, Lauren M., Wan, George J., Nelson, Winnie W.

“…Objective: Non-infectious inflammatory eye diseases (IEDs), although rare, are complex and varied and may result in detrimental effects. A systematic…”
Get full text

Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States by Albini, Thomas A., Rice, J. Bradford, White, Alan G., Johnson, Michaela, Reiff, Julie, Lima, Antonio Flavio, Bartels-Peculis, Laura, Ciepielewska, Gosia, Nelson, Winnie W.

“…Purpose: To assess the economic burden of non-infectious inflammatory eyedisease (NIIED) in a commercially-insured population in the United States Methods:…”
Get full text

Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population by Rice, J Bradford, White, Alan G, Johnson, Michaela, Wagh, Aneesha, Qin, Yimin, Bartels-Peculis, Laura, Ciepielewska, Gosia, Nelson, Winnie W

“…To quantify healthcare resource use (HCRU) and costs associated with varying levels of corticosteroid exposure. Patients with a diagnosis of selected…”
Get more information

Prescription opioid abuse: challenges and opportunities for payers by Katz, Nathaniel P, Birnbaum, Howard, Brennan, Michael J, Freedman, John D, Gilmore, Gary P, Jay, Dennis, Kenna, George A, Madras, Bertha K, McElhaney, Lisa, Weiss, Roger D, White, Alan G

“…Prescription opioid abuse and addiction are serious problems with growing societal and medical costs, resulting in billions of dollars of excess costs to…”
Get full text